Meng Yang1, Xin Li2, Pang Chun-Hong3, Huang Lin-Ping1. 1. Department of Breast Surgery, Breast Tumor Center, China-Japan Friendship Hospital, Beijing, China. 2. Institute of Clinical Science, China-Japan Friendship Hospital, Beijing, China. 3. Department of Pathology, China-Japan Friendship Hospital, Beijing, China.
Abstract
BACKGROUND: Pure mucinous breast carcinoma is a relatively rare subtype of breast malignancy. This study is to investigate the clinical and pathologic features of pure mucinous breast carcinoma. PATIENTS AND METHODS: A retrospective review of our database of patients who presented with breast cancer was performed. The medical records of 1,060 patients with invasive breast cancer who underwent surgery were reviewed. RESULTS: 28 patients with pure mucinous breast cancer were identified. The mean age was 55.28 ± 15.73 years. 17 patients underwent modified radical mastectomy; 11 underwent breast-conserving therapy. The tumor size was T1 in 19 patients, T2 in 8 patients, and T3 in 1 patient. None of the patients had lymph node metastasis. There was no distant metastasis. 18 were stage I, and 10 were stage II. Estrogen receptor, progesterone receptor, HER-2, and P53 were positive in 96, 93, 0, and 28%, respectively. Median follow-up was 42 months (range 1-84 months). 1 patient had local recurrence. The overall survival rate was 100%. CONCLUSION: Pure mucinous breast carcinoma has a favorable prognosis. Less invasive treatment might be optional. Larger data samples with longer follow-up would be necessary to gain a better understanding of this disease.
BACKGROUND: Pure mucinous breast carcinoma is a relatively rare subtype of breast malignancy. This study is to investigate the clinical and pathologic features of pure mucinous breast carcinoma. PATIENTS AND METHODS: A retrospective review of our database of patients who presented with breast cancer was performed. The medical records of 1,060 patients with invasive breast cancer who underwent surgery were reviewed. RESULTS: 28 patients with pure mucinous breast cancer were identified. The mean age was 55.28 ± 15.73 years. 17 patients underwent modified radical mastectomy; 11 underwent breast-conserving therapy. The tumor size was T1 in 19 patients, T2 in 8 patients, and T3 in 1 patient. None of the patients had lymph node metastasis. There was no distant metastasis. 18 were stage I, and 10 were stage II. Estrogen receptor, progesterone receptor, HER-2, and P53 were positive in 96, 93, 0, and 28%, respectively. Median follow-up was 42 months (range 1-84 months). 1 patient had local recurrence. The overall survival rate was 100%. CONCLUSION: Pure mucinous breast carcinoma has a favorable prognosis. Less invasive treatment might be optional. Larger data samples with longer follow-up would be necessary to gain a better understanding of this disease.
Entities:
Keywords:
Breast cancer; Mucinous carcinoma; Prognosis
Authors: Christina R Barkley; Jennifer A Ligibel; Julia S Wong; Stuart Lipsitz; Barbara L Smith; Mehra Golshan Journal: Am J Surg Date: 2008-10 Impact factor: 2.565
Authors: Juan C Paramo; Christopher Wilson; Diego Velarde; Jaime Giraldo; Robert J Poppiti; Thomas W Mesko Journal: Ann Surg Oncol Date: 2002-03 Impact factor: 5.344
Authors: K Anan; S Mitsuyama; K Tamae; K Nishihara; T Iwashita; Y Abe; T Ihara; S Nakahara; F Katsumoto; S Toyoshima Journal: Eur J Surg Oncol Date: 2001-08 Impact factor: 4.424
Authors: Emad A Rakha; Richard W G Boyce; Dalia Abd El-Rehim; Thomas Kurien; Andrew R Green; Emma C Paish; John F R Robertson; Ian O Ellis Journal: Mod Pathol Date: 2005-10 Impact factor: 7.842
Authors: S Matsukita; M Nomoto; S Kitajima; S Tanaka; M Goto; T Irimura; Y S Kim; E Sato; S Yonezawa Journal: Histopathology Date: 2003-01 Impact factor: 5.087
Authors: Ian K Komenaka; Mahmoud B El-Tamer; Andrea Troxel; Diane Hamele-Bena; Kathie-Ann Joseph; Elizabeth Horowitz; Beth-Ann Ditkoff; Freya R Schnabel Journal: Am J Surg Date: 2004-04 Impact factor: 2.565
Authors: Irean Garcia-Hernandez; Carlos A Lopez-Garcia; Servando Cardona-Huerta; Rocio Ortiz-Lopez; Nydia Paulina Herrera-Rios; B Kanagusico-Elguezabal; Esteban-Zubero Eduardo; Gabriela Sofia Gomez-Macias Journal: Int J Surg Case Rep Date: 2018-10-17